Pharmaceutical Business review

BioTime Q2 revenues rise

The company has posted a net loss of $5m for the second quarter of 2011, compared to $2.35m for the same period in 2010.

The company’s loss from operations were $4.98m, compared to 2.32m for the same period prior year.

For the six months ended 30 June 2011, the company reported total revenues of $1.58m, compared to $1.45m for the same period in 2010.

BioTime has reported net loss of $8.94m for the six months ended 30 June 2011, compared to $3.67m for the same period in 2010.

For the six months ended 30 June 2011, the company’s loss form operations were $9.01m, compared to $3.64m for the same period prior year.